Advertisement

Topics

Latest "A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock" News Stories

04:11 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock" found in our extensive news archives from over 250 global news sources.

More Information about A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock for you to read. Along with our medical data and news we also list A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock Clinical Trials, which are updated daily. BioPortfolio also has a large database of A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock Companies for you to search.

Showing "Study Compare Efficacy Safety Dosing Regimens Infusions AZD9773" News Articles 1–25 of 24,000+

Friday 22nd March 2019

Xiangxue Approved to Start China Trial of T-Cell Therapy for Solid Tumors

Guangzhou Xiangxue Life Sciences (XLifeSc), a subsidiary of Xiangxue Pharmaceutical, was approved by China's NMPA to start clinical studies of its T-cell receptor Affinity Enhanced Specific T-cell (TAEST) therapy in patients with solid tumors. Earlier, XLifeSc announced positive results from a small pilot study of the TAEST thrapy in China. Xiangxue in-licensed the therapy from Athenex, a New York...


Thursday 21st March 2019

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Pesticide Exposure Linked with Autism in Epidemiological Study http://ow.ly/UJe730o8rSk pic.twitter.com/Tl9XnYIVqm

Pesticide Exposure Linked with Autism in Epidemiological Study http://ow.ly/UJe730o8rSk  pic.twitter.com/Tl9XnYIVqm


Breast cancer metastasis is shown to be associated with increased levels of stress hormones in a mouse study reported in Nature. https://go.nature.com/2Fc9owu pic.twitter.com/FPBk51gEvk

Breast cancer metastasis is shown to be associated with increased levels of stress hormones in a mouse study reported in Nature. https://go.nature.com/2Fc9owu  pic.twitter.com/FPBk51gEvk

Some 30% of childhood cancer survivors will be infertile. A new study suggests it might be possible to save a piece of a boy’s testicular tissue and later coax it to produce mature sperm. https://buff.ly/2Cx588Z pic.twitter.com/eWdfL4xN3k

Some 30% of childhood cancer survivors will be infertile. A new study suggests it might be possible to save a piece of a boy’s testicular tissue and later coax it to produce mature sperm. https://buff.ly/2Cx588Z  pic.twitter.com/eWdfL4xN3k

BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease

STOCKHOLM, Sweden, March 21, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that its partner Eisai has initiated the global Phase 3 confirmatory study of BAN24...

There may be a way to keep CRISPR'd cells from becoming cancerous, a new study shows. https://buff.ly/2FmN6GY 

There may be a way to keep CRISPR'd cells from becoming cancerous, a new study shows. https://buff.ly/2FmN6GY 

Multiple links between stress and breast cancer progression

In mid-February, a study led by Chinese researchers established that the stress hormone epinephrine sets off a cascade of biochemical reactions that favour breast cancer growth and spread. Their work was published in The Journal of Clinical Investigation. The researchers first demonstrated the effects of chronic stress on cancer stem cell growth, in a twist on previous research that did not speci...

Popular Health Apps Share Data with Third Parties, Study Shows

(UPI) – The widespread use of mobile health apps can help more people locate prescriptions and remember to take pills. But this technology also opens people up to have all of that medical information passed along to third parties without … Read More

These are the top 10 patient safety challenges in 2019

A report from ECRI Institute outlined the 10 biggest patient safety concerns, and diagnostic errors and improper management of test results in EHRs topped the list.

BioTek 501 Pro Electrical Safety Analyzer

C $38.65 (0 Bids)End Date: Thursday Mar-28-2019 16:20:06 EDTBid now | Add to watch list Biotech365 : BioTek 501 Pro Electrical Safety Analyzer BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic … Continue reading →

CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)

SUZHOU, China, March 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) today announced that China's National Medical Products Administration (NMPA) has approved the clinical trial application to begin a Phase 1 trial in China for BLU-667 (CS3009), a highly selective and potent RET inhibitor discovered by CStone's partner Blueprint Medicines. The study is part of Blue...

Alkermes Statement on National Academies of Sciences, Engineering, and Medicine Report on Medications for Opioid Use Disorder

National Academy of Sciences (NAS) Calls for Broader Access to AllEvidence-Based Medications to Address the Opioid EpidemicIndependent Review Reinforces Evidence Supporting the Safety and Efficacy of all Three FDA-Approved Options and Underscores the Need to Broaden AccessA report published yesterday by the NAS examining existing evidence for medications to treat opioid use disorder (OUD) reinforc...

Two-drug combos built around amlodipine control BP in African study

Study Finds Cancer Drugs Can be Repurposed Beyond Known Uses

The drug sorafenib (Nexavar®) typically used for kidney and liver cancer treatment provided complete remission for breast cancer patient after lab discoveries In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to ...

IMV Inc. Announces 2018 Year-end Financial and Operational Results and Provides Updates on Key Clinical Programs

Attained multiple milestones in DECIDE1/2 clinical program in advanced ovarian cancer Achieved initial positive data from phase 2 clinical trial in DLBCL with Merck Initiated a phase 2 basket trial across five indications under a collaboration with Merck Listed on Nasdaq and changed Corpora...

Breast ultrasound and cancer detection rates increased under new laws

State breast density notification laws that mandate reporting of mammogram results can prompt further screening and modestly boost cancer detection rates, say researchers at Yale's School of Public Health and School of Medicine. Their study was published...

Part D Rebates: Policy Tweak Would Retain Manufacturer ‘Contributions’

Peter Bach’s new approach to calculating TrOOP cost in Medicare would prevent big savings to manufacturers from point-of-sale rebates.   

Phone app may help conquer fear of heights

(Reuters Health) - People who are terrified of heights may be able to conquer their phobia using a virtual reality app and an inexpensive set of cardboard VR googles, a Dutch study suggests.

Mitochondria may have role to play in cancer treatment efficacy http://ow.ly/RWLD30o8sdx pic.twitter.com/uDj9WQKGv2

Mitochondria may have role to play in cancer treatment efficacy http://ow.ly/RWLD30o8sdx  pic.twitter.com/uDj9WQKGv2

ESO Enters into Exclusive Partnership with NarcBox to Help Agencies and Departments Manage Narcotic Distribution and Tracking

Emerging Drug Enforcement Administration (DEA) rule changes related to the transport and dispensing of controlled substances will have a major impact in the industry ESO, the leading data and software company serving emergency medical services (EMS), fire departments and hospitals, today announced it has entered into an exclusive partnership wit...

ESO Announces ESO Academy to Provide Digitally-Based Training and Education to EMS and Fire Personnel

Online courses to provide in-depth ESO product training, ESO product certifications and extensive catalog of continuing education classes ESO, the leading data and software company serving emergency medical services (EMS), fire departments and hospitals, today announced the launch of ESO Academy to provide comprehensive E

Certain Dietary Patterns Linked to Cognitive Performance

THURSDAY, March 21, 2019 -- Higher Mediterranean diet (MedDiet) and A Priori Diet Quality Score (APDQS) scores are associated with better cognitive performance in midlife, according to a study published online March 6 in Neurology. Claire T. McEvoy,...

Tighter Gun Laws = Safer Schools

THURSDAY, March 21, 2019 -- Stricter gun laws keep U.S. high school students safer, a new study says. Surveying nearly 100,000 high school students, researchers found that tightening of state gun laws was associated with a lower risk of teens being...

High-fructose corn syrup boosts intestinal tumour growth in mice

Does sugar directly feed cancers, boosting their growth? The answer seems to be 'Yes' at least in mice according to a study led by researchers at Baylor College of Medicine and Weill Cornell Medicine. Their study, published in Science, showed that...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks